GINKGO BIOWORKS HOLDINGS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
GINKGO BIOWORKS HOLDINGS, INC. (DNA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $7.48 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2026-02-26
- GINKGO BIOWORKS HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2025 was $7.48, a 34.10% decline from fiscal 2024.
- GINKGO BIOWORKS HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2024 was $11.35, a 80.16% decline from fiscal 2023.
- GINKGO BIOWORKS HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2023 was $57.20, a 25.52% decline from fiscal 2022.
- GINKGO BIOWORKS HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2022 was $76.80, a 756.19% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | $7.48 10-K · filed 2026-02-26 | |||||
| 2025-09-30 | $7.50 10-Q · filed 2025-11-06 | |||||
| 2025-06-30 | $7.50 10-Q · filed 2025-08-07 | |||||
| 2024-12-31 | $11.35 10-K · filed 2026-02-26 | |||||
| 2024-09-30 | $14.14 10-Q · filed 2025-11-06 | |||||
| 2024-06-30 | $14.00 10-Q · filed 2025-08-07 | $0.35 10-Q · filed 2024-08-08 | ||||
| 2023-12-31 | $57.20 10-K · filed 2026-02-26 | $1.43 10-K · filed 2024-02-29 | ||||
| 2023-09-30 | $57.20 10-Q · filed 2024-11-12 | $1.43 10-Q · filed 2023-11-08 | ||||
| 2023-06-30 | $1.43 10-Q · filed 2024-08-08 | |||||
| 2022-12-31 | $76.80 10-K · filed 2025-02-25 | $1.92 10-K · filed 2023-03-13 | ||||
| 2022-09-30 | $1.92 10-Q · filed 2023-11-08 | |||||
| 2022-06-30 | $1.84 10-Q · filed 2023-08-09 | |||||
| 2021-12-31 | $8.97 10-K · filed 2024-02-29 | |||||
| 2021-09-30 | $8.97 10-Q · filed 2022-11-14 |